Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15
Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15
杰富瑞开始以买入评级对ProKidny进行报道，宣布目标价为15美元
Jefferies analyst Kelly Shi initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $15.
杰富瑞分析师Kelly Shih对ProKidney(纳斯达克代码：PROK)的报道给予买入评级，并宣布目标价为15美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。